Searched for
COVID ANTIBODY
First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- Hantavirus cruise ship outbreak: What is Andes strain? Symptoms, mortality rate, treatment, vaccines and all details you need to knowHantavirus Andes strain update: A deadly Andes strain hantavirus outbreak linked to the MV Hondius cruise ship has resulted in three deaths...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
- Quality of antibodies improves for months after COVID-19 vaccination: StudyThe findings, published on Tuesday in the journal Nature, suggest that declining antibody levels in the months after vaccination primarily ...
- Exercise may amplify the benefits of a COVID-19 or flu vaccine shotPeople who exercised for 90 minutes right after their shot subsequently produced more antibodies than people who did not.
- Mild to moderate-intensity exercise after getting Covid-19 vaccine may boost antibodies, says studyThe findings could directly benefit people with a range of fitness levels.
- Researchers find new antibody that can help block Covid transmission in cellsThis approach can prove to be effective against emerging Covid variants.
- USFDA revokes emergency use status to two Covid antibody therapies"Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequ...
- Covid: Why T cell vaccines could be the key to long-term immunityEvidence directly on COVID and T cells is still being gathered. However, it's gradually becoming clearer that T cells do seem to play a big...
- Covid antibodies found in breast milk of vaccinated, infected mothers, says studyThe researchers collected samples from 77 mothers -- 47 in the infected group, 30 in the vaccine group.
- One in every two families paid over Rs 750 for COVID antibody test in India: SurveyAccording to the survey, 29 per cent of the respondents said they paid Rs 1,000 or more during their COVID antibody test. Further, 21 per c...
- Antibodies detectable up to 7 months after Covid infection, number depends on severity of diseaseThe study revealed that 90 per cent of subjects have detectable antibodies.
- Everyone's talking about Covid-19 antibody tests. What do they tell us?Studies are still underway to determine what antibody level would be needed for immunity.
- Israel isolates coronavirus antibody in 'significant breakthrough': MinisterThe "monoclonal neutralising antibody" developed at the Israel Institute for Biological Research (IIBR) "can neutralise it (the disease-cau...
Load More
